scholarly journals Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm

2021 ◽  
Vol 8 ◽  
Author(s):  
Ariel Kenig ◽  
Yotam Kolben ◽  
Rabea Asleh ◽  
Offer Amir ◽  
Yaron Ilan

Heart failure is a major public health problem, which is associated with significant mortality, morbidity, and healthcare expenditures. A substantial amount of the morbidity is attributed to volume overload, for which loop diuretics are a mandatory treatment. However, the variability in response to diuretics and development of diuretic resistance adversely affect the clinical outcomes. Morevoer, there exists a marked intra- and inter-patient variability in response to diuretics that affects the clinical course and related adverse outcomes. In the present article, we review the mechanisms underlying the development of diuretic resistance. The role of the autonomic nervous system and chronobiology in the pathogenesis of congestive heart failure and response to therapy are also discussed. Establishing a novel model for overcoming diuretic resistance is presented based on a patient-tailored variability and chronotherapy-guided machine learning algorithm that comprises clinical, laboratory, and sensor-derived inputs, including inputs from pulmonary artery measurements. Inter- and intra-patient signatures of variabilities, alterations of biological clock, and autonomic nervous system responses are embedded into the algorithm; thus, it may enable a tailored dose regimen in a continuous manner that accommodates the highly dynamic complex system.

1995 ◽  
Vol 50 (3) ◽  
pp. 373-374
Author(s):  
Hiroshi Sato ◽  
Machiko Yamamoto ◽  
Shichiro Abe ◽  
Akihisa Yabe ◽  
Hiroyuki Iinuma ◽  
...  

2011 ◽  
Vol 148 (1) ◽  
pp. 53-58 ◽  
Author(s):  
Linda M. Ueno ◽  
Luciano F. Drager ◽  
Ana C.T. Rodrigues ◽  
Maria U.P.B. Rondon ◽  
Wilson Mathias ◽  
...  

2007 ◽  
Vol 21 (6) ◽  
Author(s):  
Case G VanDongen ◽  
A Kenouche ◽  
B Banville ◽  
A Kale ◽  
H Bhagavan ◽  
...  

2014 ◽  
Vol 3 (2) ◽  
pp. 120
Author(s):  
Peter J Schwartz ◽  

An imbalance of the autonomic nervous system, with reduced vagal and increased sympathetic activity, contributes to pathogenesis and clinical deterioration in heart failure (HF). Experimental studies have demonstrated that vagal stimulation (VS) has an antifibrillatory effect that has proved beneficial in animal models of HF. The potential value of chronic VS in man was first investigated with an implantable neuro-stimulator capable of delivering low current pulses with adjustable parameters to stimulate the right vagus. The results of a pilot study and a small multicentre clinical trial of VS in HF patients appeared to show a favourable clinical effect, and feasibility and safety data were encouraging. An ongoing pivotal clinical trial will provide a definitive assessment of the efficacy and usefulness of chronic VS in HF patients.This approach represents a new and exciting possibility for the management of HF that will provide clinicians with a novel tool to modulate non-pharmacologically the autonomic nervous system in patients with moderate-to-advanced HF.


2018 ◽  
Vol 69 (3) ◽  
pp. 728-730
Author(s):  
Sebastian Cozma ◽  
Cristian Martu ◽  
Cristina Mihaela Ghiciuc ◽  
Francesca Romana Patacchioli ◽  
Lucia Corina Dima Cozma

Salivary biomarkers have developed into biological clinical research because they are accessible and easily obtained. Salivary a-amylase was proposed as an associat marker of salivary cortisol in assessing stress and at the same time as a possible non-invasive indicator of autonomic nervous system activation. Studies conducted so far have tested a-amylase activity in psychiatric disorders, diabetic neuropathy, lung disease, and autonomic nervous system activation in hypertension or heart failure.


Sign in / Sign up

Export Citation Format

Share Document